Vijaya Diagnostic Centre Limited has announced the appointment of Mr. Satyanarayana Murthy Chavali and Mr. Dipinder Singh Sekhon as Additional Directors in the capacity of Non-Executive Independent Directors. These appointments, effective from May 26, 2026, are subject to approval by the company’s shareholders. Both individuals bring extensive leadership experience and expertise in their respective fields to the Board.
Strategic Leadership Expansion
Vijaya Diagnostic Centre has strengthened its governance structure by appointing two seasoned professionals to its Board of Directors. The appointments are aimed at leveraging deep industry insights to support the company’s long-term strategic growth and organizational excellence.
Profile of New Directors
Mr. Satyanarayana Murthy Chavali joins the Board with extensive experience in the pharmaceutical and life sciences sectors. Having previously served as the CEO of Aurigene Discovery Technologies Limited and held senior roles at Dr. Reddy’s Laboratories, he brings profound expertise in drug discovery, corporate governance, and large-scale organizational management. He has been appointed for a term of 5 years.
Mr. Dipinder Singh Sekhon is a recognized technology entrepreneur and AI strategist with over two decades of experience in artificial intelligence, medical imaging, and computer vision. As the founder of initiatives like iKITES.ai and Ophthal.ai, he brings critical digital innovation and technology leadership to the company. He has been appointed for a term of 2 years.
Commitment to Corporate Governance
The company confirmed that neither director has any existing relationships with current Board members. Additionally, both appointees have been verified to be in good standing, with no history of debarment from holding the office of director by any regulatory authority. These appointments reflect the company’s commitment to maintaining a high standard of independent oversight and expertise.
Source: BSE
